• by admin
• (0) Comments

India’s free-trade agreement with Oman now includes traditional medicine systems (Ayush)

Marking a significant step toward global recognition and export growth of Indian traditional health products. The move is expected to strengthen bilateral trade while opening new international markets for evidence-based AYUSH offerings.

News Source: (The Economic Times)

---

Aurobindo Pharma received a Form 483 with observations from the USFDA 

The US Food and Drug Administration (USFDA) has issued a Form 483 with observations to Aurobindo Pharma following an inspection of its manufacturing facility in Andhra Pradesh. The observations relate to regulatory and quality processes and will require timely corrective action from the company.

News Source: (Rediff Money)

Sun Pharma’s Baska facility was classified by the USFDA as “Official Action Indicated (OAI)”

Sun Pharmaceutical Industries’ Baska manufacturing facility has been classified as “Official Action Indicated (OAI)” by the USFDA after an inspection. While the classification signals compliance concerns, it does not immediately impact product supplies to the US market.

News Source: (The Economic Times)

---

📌 Emerging Indian Healthcare Innovation / Infrastructure

Centre of Excellence for Telemedicine Services approved at King George’s Medical University (KGMU), Lucknow — 

The Centre has approved a Centre of Excellence for Telemedicine Services at King George’s Medical University (KGMU), Lucknow. The initiative aims to enhance telemedicine quality, training, and rural healthcare access, with support from partners including the Bill & Melinda Gates Foundation.

News Source: (The Times of India)

Bharat Innovates Basecamp opened at IIT Gandhinagar 

The Bharat Innovates Basecamp has been inaugurated at IIT Gandhinagar to showcase deep-tech innovations, including healthcare AI and med-tech solutions. The platform aims to connect Indian startups with global investors under the government’s Viksit Bharat 2047 vision.

News Source: (The Times of India)

---

Disclaimer: The information provided in this newsletter is for general informational purposes only and reflects the latest updates and trends across various sectors. While we strive for accuracy, Aristocrat Media assumes no responsibility for errors or omissions. Readers are encouraged to verify details independently and consult appropriate professionals before making decisions.

Stay Connected: Don’t miss out on our updates! Subscribe to our channel and follow us on LinkedIn, YouTube, and Instagram for more insights and exclusive content.

Your feedback matters! If you have suggestions or topics you’d like us to cover, feel free to reach out.

Email – info@aristocrat-media.com